Fricker G - Search Results

1

Toward Optimized ⁸⁹Zr-Immuno-PET: Side-by-Side Comparison of [⁸⁹Zr]Zr-DFO-, [⁸⁹Zr]Zr-3,4,3-(LI-1,2-HOPO)- and [⁸⁹Zr]Zr-DFO*-Cetuximab for Tumor Imaging: Which Chelator Is the Most Suitable?

Damerow H, Cheng X, von Kiedrowski V, Schirrmacher R, Wängler B, Fricker G, Wängler C. Damerow H, et al. Among authors: fricker g. Pharmaceutics. 2022 Oct 4;14(10):2114. doi: 10.3390/pharmaceutics14102114. Pharmaceutics. 2022. PMID: 36297549 Free PMC article.

2

Shuttle-cargo fusion molecules of transport peptides and the hD2/3 receptor antagonist fallypride: a feasible approach to preserve ligand-receptor binding?

Wängler C, Chowdhury S, Höfner G, Djurova P, Purisima EO, Bartenstein P, Wängler B, Fricker G, Wanner KT, Schirrmacher R. Wängler C, et al. Among authors: fricker g. J Med Chem. 2014 May 22;57(10):4368-81. doi: 10.1021/jm5004123. Epub 2014 May 8. J Med Chem. 2014. PMID: 24779610

3

Comparative Assessment of Complex Stabilities of Radiocopper Chelating Agents by a Combination of Complex Challenge and in vivo Experiments.

Litau S, Seibold U, Vall-Sagarra A, Fricker G, Wängler B, Wängler C. Litau S, et al. Among authors: fricker g. ChemMedChem. 2015 Jul;10(7):1200-8. doi: 10.1002/cmdc.201500132. Epub 2015 May 25. ChemMedChem. 2015. PMID: 26011290

4

Next Generation of SiFAlin-Based TATE Derivatives for PET Imaging of SSTR-Positive Tumors: Influence of Molecular Design on In Vitro SSTR Binding and In Vivo Pharmacokinetics.

Litau S, Niedermoser S, Vogler N, Roscher M, Schirrmacher R, Fricker G, Wängler B, Wängler C. Litau S, et al. Among authors: fricker g. Bioconjug Chem. 2015 Dec 16;26(12):2350-9. doi: 10.1021/acs.bioconjchem.5b00510. Epub 2015 Oct 14. Bioconjug Chem. 2015. PMID: 26420336

5

Design and synthesis of a fluorinated quinazoline-based type-II Trk inhibitor as a scaffold for PET radiotracer development.

Bernard-Gauthier V, Mahringer A, Vesnaver M, Fricker G, Schirrmacher R. Bernard-Gauthier V, et al. Among authors: fricker g. Bioorg Med Chem Lett. 2017 Jun 15;27(12):2771-2775. doi: 10.1016/j.bmcl.2017.04.064. Epub 2017 Apr 21. Bioorg Med Chem Lett. 2017. PMID: 28476569

6

A Kinome-Wide Selective Radiolabeled TrkB/C Inhibitor for in Vitro and in Vivo Neuroimaging: Synthesis, Preclinical Evaluation, and First-in-Human.

Bernard-Gauthier V, Bailey JJ, Mossine AV, Lindner S, Vomacka L, Aliaga A, Shao X, Quesada CA, Sherman P, Mahringer A, Kostikov A, Grand'Maison M, Rosa-Neto P, Soucy JP, Thiel A, Kaplan DR, Fricker G, Wängler B, Bartenstein P, Schirrmacher R, Scott PJH. Bernard-Gauthier V, et al. Among authors: fricker g. J Med Chem. 2017 Aug 24;60(16):6897-6910. doi: 10.1021/acs.jmedchem.7b00396. Epub 2017 Jul 21. J Med Chem. 2017. PMID: 28696690

7

Synthesis, in vitro and in vivo evaluation of ¹⁸F-fluoronorimatinib as radiotracer for Imatinib-sensitive gastrointestinal stromal tumors.

Prause M, Niedermoser S, Wängler C, Decristoforo C, Seibold U, Riester S, Taguchi T, Schirrmacher R, Fricker G, Wängler B. Prause M, et al. Among authors: fricker g. Nucl Med Biol. 2018 Feb;57:1-11. doi: 10.1016/j.nucmedbio.2017.11.004. Epub 2017 Nov 17. Nucl Med Biol. 2018. PMID: 29175467

8

Identification of [¹⁸F]TRACK, a Fluorine-18-Labeled Tropomyosin Receptor Kinase (Trk) Inhibitor for PET Imaging.

Bernard-Gauthier V, Mossine AV, Mahringer A, Aliaga A, Bailey JJ, Shao X, Stauff J, Arteaga J, Sherman P, Grand'Maison M, Rochon PL, Wängler B, Wängler C, Bartenstein P, Kostikov A, Kaplan DR, Fricker G, Rosa-Neto P, Scott PJH, Schirrmacher R. Bernard-Gauthier V, et al. Among authors: fricker g. J Med Chem. 2018 Feb 22;61(4):1737-1743. doi: 10.1021/acs.jmedchem.7b01607. Epub 2018 Jan 5. J Med Chem. 2018. PMID: 29257860

9

Design, Synthesis, In Vitro, and Initial In Vivo Evaluation of Heterobivalent Peptidic Ligands Targeting Both NPY(Y₁)- and GRP-Receptors-An Improvement for Breast Cancer Imaging?

Vall-Sagarra A, Litau S, Decristoforo C, Wängler B, Schirrmacher R, Fricker G, Wängler C. Vall-Sagarra A, et al. Among authors: fricker g. Pharmaceuticals (Basel). 2018 Jul 4;11(3):65. doi: 10.3390/ph11030065. Pharmaceuticals (Basel). 2018. PMID: 29973529 Free PMC article.

10

Radioligands for Tropomyosin Receptor Kinase (Trk) Positron Emission Tomography Imaging.

Schirrmacher R, Bailey JJ, Mossine AV, Scott PJH, Kaiser L, Bartenstein P, Lindner S, Kaplan DR, Kostikov A, Fricker G, Mahringer A, Rosa-Neto P, Schirrmacher E, Wängler C, Wängler B, Thiel A, Soucy JP, Bernard-Gauthier V. Schirrmacher R, et al. Among authors: fricker g. Pharmaceuticals (Basel). 2019 Jan 3;12(1):7. doi: 10.3390/ph12010007. Pharmaceuticals (Basel). 2019. PMID: 30609832 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

251 results

Search Page